Sandra Revill Tremulis: The Major Trial Testing Whether Lp(a) Lowering Saves Lives
Sandra Revill Tremulis, Marketing Consultant at Tremulis Stractical Marketing Consulting and Founder of the Lipoprotein(a) Foundation, shared a post on LinkedIn about a recent article by Leslie Cho et al, published in American Heart Journal:
“ Pelacarsen — the major trial testing whether Lp(a) lowering saves lives
Pelacarsen outcomes program — Lp(a)HORIZON trial design/rationale
Executive summary: Defines the pivotal outcomes framework for Lp(a): large, multinational, placebo-controlled phase 3 trial in established CVD with elevated Lp(a), testing whether targeted Lp(a) lowering reduces MACE. Value for clinicians/researchers: clarifies inclusion thresholds, endpoints, event-driven design, and the intended inferential strategy—useful when interpreting forthcoming results and planning complementary studies (imaging, biomarkers, implementation).
This is one of the most important trials in cardiovascular medicine today.”
Title: Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)
Authors: Leslie Cho , Stephen J Nicholls , Børge G Nordestgaard , Ulf Landmesser , Sotirios Tsimikas , Michael J Blaha , Eran Leitersdorf , A Michael Lincoff , Anastasia Lesogor , Brian Manning , Plamen Kozlovski , Hui Cao , Jing Wang , Steven E Nissen
Read the Full Article in American Heart Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 25, 2026, 16:00Randa Bascharon: When to Consider Wharton’s Jelly in Tendon, Ligament, and Joint Conditions
-
Mar 25, 2026, 15:56Boris Pasche: Karmanos Cancer Institute Leads Innovation in Cancer and Hematologic Disease Treatment
-
Mar 25, 2026, 15:52Indunil Karunarathna: Kawasaki Disease at the Intersection of Immunology, Cardiology, and Vascular Biology
-
Mar 25, 2026, 15:48Micah Grey: Reflecting on an Incredible Experience at the THSNA Congress
-
Mar 25, 2026, 15:45Christi Miller: Exploring Key Facts about Hemophilia During Bleeding Disorders Awareness Month
-
Mar 25, 2026, 15:44Stéphane Laurent: Why the Relationship Between AfSBT and ISBT Matters in Blood Management
-
Mar 25, 2026, 15:36Seema Dawood: EDTA-Induced Platelet Satellitism
-
Mar 25, 2026, 15:35ABO-Incompatible Transfusions and Severe Allergic Reactions – ISBT
-
Mar 25, 2026, 15:14Critical Gaps in AF Stroke Prevention – JTH